Gamida Cell Ltd. Ordinary Shares
GMDA
GMDA was delisted on the 5th of April, 2024.
17 hedge funds and large institutions have $31.8M invested in Gamida Cell Ltd. Ordinary Shares in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
573% more capital invested
Capital invested by funds: $4.73M → $31.8M (+$27.1M)
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
89% more funds holding
Funds holding: 9 → 17 (+8)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.6M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$7.85M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$7.85M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.16M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$136K |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$38.6K |
| 3 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$10K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$644 |
GMDA Hedge Fund Activity: Q2 2019 in Review
17 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Gamida Cell Ltd. Ordinary Shares (GMDA) for Q2 2019, worth a combined $31.8M — up 573% from $4.73M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GMDA positions and 2 closed out — a net gain of 8 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $21.6M. The largest seller was UBS Group, exiting entirely with an estimated $136K sold.
- 17 institutional investors held Gamida Cell Ltd. Ordinary Shares (GMDA) as of Q2 2019, up from 9 in Q1 2019.
- Funds reported $31.8M of Gamida Cell Ltd. Ordinary Shares stock for Q2 2019, up 573% quarter-over-quarter.
- 10 funds opened new Gamida Cell Ltd. Ordinary Shares positions in Q2 2019 and 2 closed out, a net change of +8 holders.
- The largest Gamida Cell Ltd. Ordinary Shares buyer in Q2 2019 was Fidelity Investments, an estimated $21.6M added.
- The largest Gamida Cell Ltd. Ordinary Shares seller in Q2 2019 was UBS Group, an estimated $136K sold.
Based on aggregated 13F filings for Q2 2019.